Amicus Therapeutics Inc. (FOLD)
NASDAQ: FOLD
· Real-Time Price · USD
7.40
0.28 (3.93%)
At close: Aug 15, 2025, 3:59 PM
7.33
-0.95%
After-hours: Aug 15, 2025, 05:04 PM EDT
Amicus Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 154.69M | 125.25M | 149.71M | 141.52M | 126.67M | 110.4M | 115.08M | 103.5M | 94.5M | 86.27M | 88.1M | 81.69M | 80.73M | 78.72M | 82.15M | 79.55M | 77.41M | 66.4M |
Cost of Revenue | 15.22M | 11.7M | 10.5M | 13.28M | 13.44M | 15.72M | 13.51M | 9.95M | 9.11M | 6.94M | 9.38M | 13.44M | 8.2M | 7.58M | 7.85M | 11.7M | 8.38M | 6.54M |
Gross Profit | 139.47M | 113.55M | 139.21M | 128.24M | 113.23M | 94.68M | 101.58M | 93.56M | 85.39M | 79.33M | 78.71M | 68.25M | 72.53M | 71.13M | 74.3M | 67.85M | 69.03M | 59.86M |
Operating Income | -9.47M | -7.95M | 9.93M | 21.66M | 14.97M | -21.68M | -3.69M | -17.02M | -18.86M | -37.64M | -40.74M | -33.27M | -60.61M | -69.91M | -72.15M | -42.4M | -38.83M | -53.05M |
Interest Income | 843K | 812K | 1.42M | 1.08M | 1.37M | 1.54M | 1.67M | 1.47M | 1.74M | 2.2M | 1.97M | 563K | 356K | 133K | 186K | 108K | 50K | 165K |
Pretax Income | -19.18M | -18.05M | 7.93M | 6.79M | 108K | -43.58M | -31.66M | -24.7M | -40.52M | -53.22M | -70.08M | -29.26M | -61.25M | -81.45M | -80.3M | -50.48M | -46.7M | -64.08M |
Net Income | -24.42M | -21.69M | 14.74M | -6.73M | -15.7M | -48.42M | -33.84M | -21.58M | -43.23M | -52.93M | -55.87M | -33.29M | -62.16M | -85.26M | -83.28M | -50.29M | -51.23M | -65.66M |
Selling & General & Admin | 84.54M | 91.83M | 86.67M | 75.11M | 73.58M | 88.03M | 70.24M | 65.65M | 65.42M | 73.96M | 54.27M | 47.27M | 53.38M | 58.12M | 57.6M | 46.11M | 42.28M | 46.73M |
Research & Development | 60.85M | 27.84M | 30.19M | 26.16M | 24.68M | 28.33M | 35.03M | 40.7M | 35.15M | 41.5M | 63.87M | 52.97M | 78.32M | 81.52M | 85.6M | 59.33M | 63M | 64.12M |
Other Expenses | n/a | n/a | 26.42M | n/a | n/a | n/a | n/a | n/a | -10.9M | 1.51M | 1.31M | 1.29M | 7.27M | 1.41M | -172K | 237K | 234K | -3.2M |
Operating Expenses | 145.39M | 121.5M | 134.59M | 101.27M | 98.26M | 116.36M | 105.27M | 106.36M | 102.78M | 116.96M | 119.46M | 101.53M | 133.03M | 141.04M | 144.72M | 106.96M | 106.85M | 112.45M |
Interest Expense | -34.48M | 11.46M | 11.96M | 12.69M | 12.51M | 12.44M | 12.83M | 12.99M | 12.49M | 11.84M | 11.1M | 9.62M | 8.26M | 8.15M | 8.16M | 8.16M | 8.15M | 7.99M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 160.61M | 133.2M | 139.78M | 119.86M | 111.7M | 132.08M | 118.77M | 116.3M | 111.89M | 123.91M | 128.84M | 114.96M | 141.23M | 148.63M | 152.57M | 118.66M | 115.23M | 118.99M |
Income Tax Expense | -12.52M | 3.64M | -6.8M | 13.51M | 15.8M | 4.84M | 2.18M | 3.13M | 2.71M | -287K | -14.21M | 4.02M | 911K | 3.81M | 2.98M | -182K | 4.53M | 1.58M |
Shares Outstanding (Basic) | 307.97M | 307.69M | 304.38M | 304.69M | 303.77M | 302.9M | 293.59M | 295.76M | 292.8M | 291.34M | 281.11M | 289.22M | 291.97M | 288.48M | 267.46M | 267.46M | 266.4M | 264.37M |
Shares Outstanding (Diluted) | 307.97M | 307.69M | 304.38M | 304.69M | 303.77M | 302.9M | 293.59M | 295.76M | 292.8M | 291.34M | 281.11M | 289.22M | 291.97M | 288.48M | 267.46M | 267.46M | 266.4M | 264.37M |
EPS (Basic) | -0.08 | -0.07 | 0.05 | -0.02 | -0.05 | -0.16 | -0.12 | -0.07 | -0.15 | -0.18 | -0.2 | -0.12 | -0.21 | -0.3 | -0.31 | -0.19 | -0.19 | -0.25 |
EPS (Diluted) | -0.08 | -0.07 | 0.05 | -0.02 | -0.05 | -0.16 | -0.12 | -0.07 | -0.15 | -0.18 | -0.2 | -0.12 | -0.21 | -0.3 | -0.31 | -0.19 | -0.19 | -0.25 |
EBITDA | -69.56M | -4.75M | 21.93M | 21.65M | 14.8M | -28.99M | -16.65M | -9.49M | -25.82M | -36.13M | -57.67M | -18.36M | -51.66M | -71.89M | -70.61M | -40.79M | -36.98M | -54.49M |
EBIT | n/a | -6.59M | 19.89M | 19.48M | 12.62M | -31.15M | -18.83M | -11.72M | -28.02M | -41.38M | -58.98M | -19.64M | -52.99M | -73.3M | -72.13M | -42.31M | -38.55M | -56.09M |
Depreciation & Amortization | 1.85M | 1.84M | 2.04M | 2.17M | 2.18M | 2.15M | 2.18M | 2.23M | 2.21M | 1.26M | 1.31M | 1.29M | 1.33M | 1.41M | 1.52M | 1.52M | 1.57M | 1.6M |